What is it about?
One of the first RCTs to show metabolic effects in detail following per oral administration of L reuteri DSM 17938 or placebo in type 2 diabetes patients. Diversity of gut microbiota may play a for getting a positive effect on metabolic control after L reuteri DSM 17938.
Featured Image
Why is it important?
This study shows that the metabolic response can vary considerably in type 2 diabetes patients following probiotic treatment. Our results suggest that it is important to know the gut microbiota composition to predict whether there will be a positive metabolic effect after L reuteri DSM 17938.
Perspectives
Larger randomized clinical trials using Lactobacillus strains are needed to better understand if positive metabolic long term effects may be achieved in human subjects.
Prof Per-Anders Jansson
University of Gothenburg
Read the Original
This page is a summary of: Metabolic effects ofLactobacillus reuteriDSM 17938 in people with type 2 diabetes: A randomized controlled trial, Diabetes Obesity and Metabolism, February 2017, Wiley,
DOI: 10.1111/dom.12861.
You can read the full text:
Contributors
The following have contributed to this page
